BMEA: Biomea Fusion, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 61.24
Enterprise Value ($M) 25.38
Book Value ($M) 28.74
Book Value / Share 0.76
Price / Book 2.13
NCAV ($M) 18.37
NCAV / Share 0.49
Price / NCAV 3.33

Profitability (mra)
Return on Invested Capital (ROIC) -3.51
Return on Assets (ROA) -0.76
Return on Equity (ROE) -0.95

Liquidity (mrq)
Quick Ratio 2.25
Current Ratio 2.25

Balance Sheet (mrq) ($M)
Current Assets 44.69
Assets 55.05
Liabilities 26.32
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -144.07
Net Income -138.43

Cash Flow Statement (mra) ($M)
Cash From Operations -119.89
Cash from Investing -0.36
Cash from Financing 1.67

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Baker Bros. Advisors Lp 4.00 -31.15
11-12 13G/A Laurion Capital Management LP 0.00 -100.00
07-10 13G/A State Street Corp 1.88 -84.94

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 183,610 510,558 35.96
2025-05-08 160,128 515,214 31.08
2025-05-07 135,333 1,113,531 12.15
2025-05-06 503,378 1,401,833 35.91
2025-05-05 74,901 393,469 19.04

(click for more detail)

Similar Companies
BEAM – Beam Therapeutics Inc. BIIB – Biogen Inc.
BLUE – bluebird bio, Inc. BMRN – BioMarin Pharmaceutical Inc.
BPMC – Blueprint Medicines Corporation


Financial data and stock pages provided by
Fintel.io